Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 4233 entries
Sorted by: Best Match Show Resources per page
[Immunological aspects of various oral diseases. I. Introduction].

Archivio stomatologico

Gombos F, Serpico R, Astarita GP.
PMID: 3870076
Arch Stomatol (Napoli). 1985 Apr-Jun;26(2):145-52.

No abstract available.

Cite
Gombos F, Serpico R, Astarita GP. Aspetti immunologici di alcune malattie del cavo orale. Nota I. Considerazioni introduttive. [Immunological aspects of various oral diseases. I. Introduction]. Arch Stomatol (Napoli). 1985;26(2):145-52
Gombos, F., Serpico, R., & Astarita, G. P. (1985). Aspetti immunologici di alcune malattie del cavo orale. Nota I. Considerazioni introduttive. [Immunological aspects of various oral diseases. I. Introduction]. Archivio stomatologico, 26(2), 145-52.
Gombos, F, et al. "Aspetti immunologici di alcune malattie del cavo orale. Nota I. Considerazioni introduttive." [Immunological aspects of various oral diseases. I. Introduction]. Archivio stomatologico vol. 26,2 (1985): 145-52.
Gombos F, Serpico R, Astarita GP. Aspetti immunologici di alcune malattie del cavo orale. Nota I. Considerazioni introduttive. [Immunological aspects of various oral diseases. I. Introduction]. Arch Stomatol (Napoli). 1985 Apr-Jun;26(2):145-52. Italian. PMID: 3870076.
Copy Download .nbib Format: NLM
Study on the influence of adsorbent substances against the antigen activity of inactivated orovaccines.

Journal of chemotherapy (Florence, Italy)

Casetta P, Negretti F.
PMID: 1517807
J Chemother. 1992 Jun;4(3):145-54. doi: 10.1080/1120009x.1992.11739154.

Specific IgAGM, IgA and IgG levels were evaluated in two groups of rabbits orally treated with inactivated vaccine consisting of Escherichia coli, Proteus vulgaris, Staphylococcus aureus and Streptococcus faecalis and with the same vaccine supplemented with charcoal and kaolin,...

Cite
Casetta P, Negretti F. Study on the influence of adsorbent substances against the antigen activity of inactivated orovaccines. J Chemother. 1992;4(3):145-54doi: 10.1080/1120009x.1992.11739154.
Casetta, P., & Negretti, F. (1992). Study on the influence of adsorbent substances against the antigen activity of inactivated orovaccines. Journal of chemotherapy (Florence, Italy), 4(3), 145-54. https://doi.org/10.1080/1120009x.1992.11739154
Casetta, P, and Negretti, F. "Study on the influence of adsorbent substances against the antigen activity of inactivated orovaccines." Journal of chemotherapy (Florence, Italy) vol. 4,3 (1992): 145-54. doi: https://doi.org/10.1080/1120009x.1992.11739154
Casetta P, Negretti F. Study on the influence of adsorbent substances against the antigen activity of inactivated orovaccines. J Chemother. 1992 Jun;4(3):145-54. doi: 10.1080/1120009x.1992.11739154. PMID: 1517807.
Copy Download .nbib Format: NLM
Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.

Cancer research

Schroff RW, Foon KA, Beatty SM, Oldham RK, Morgan AC.
PMID: 3871353
Cancer Res. 1985 Feb;45(2):879-85.

Human anti-murine immunoglobulin responses were assessed in serum from three groups of patients receiving murine monoclonal antibody therapy. Each of the three patient groups responded differently. Chronic lymphocytic leukemia patients demonstrated little or no preexisting murine immunoglobulin G-reactive antiglobulin...

Cite
Schroff RW, Foon KA, Beatty SM, et al. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res. 1985;45(2):879-85
Schroff, R. W., Foon, K. A., Beatty, S. M., Oldham, R. K., & Morgan, A. C. (1985). Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer research, 45(2), 879-85.
Schroff, R W, et al. "Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy." Cancer research vol. 45,2 (1985): 879-85.
Schroff RW, Foon KA, Beatty SM, Oldham RK, Morgan AC. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res. 1985 Feb;45(2):879-85. PMID: 3871353.
Copy Download .nbib Format: NLM
[Immunoglobulins in virological research and in the prevention of infections].

Voprosy virusologii

Pshenichnov VA, Krasnianskiĭ VP, Mikhaĭlov VV.
PMID: 1471338
Vopr Virusol. 1992 Jul-Aug;37(4):178-80.

No abstract available.

Cite
Pshenichnov VA, Krasnianskiĭ VP, Mikhaĭlov VV. Immunoglobuliny v virusologicheskikh issledovaniiakh i pri profilaktike nekotorykh infektsiĭ. [Immunoglobulins in virological research and in the prevention of infections]. Vopr Virusol. 1992;37(4):178-80
Pshenichnov, V. A., Krasnianskiĭ, V. P., & Mikhaĭlov, V. V. (1992). Immunoglobuliny v virusologicheskikh issledovaniiakh i pri profilaktike nekotorykh infektsiĭ. [Immunoglobulins in virological research and in the prevention of infections]. Voprosy virusologii, 37(4), 178-80.
Pshenichnov, V A, et al. "Immunoglobuliny v virusologicheskikh issledovaniiakh i pri profilaktike nekotorykh infektsiĭ." [Immunoglobulins in virological research and in the prevention of infections]. Voprosy virusologii vol. 37,4 (1992): 178-80.
Pshenichnov VA, Krasnianskiĭ VP, Mikhaĭlov VV. Immunoglobuliny v virusologicheskikh issledovaniiakh i pri profilaktike nekotorykh infektsiĭ. [Immunoglobulins in virological research and in the prevention of infections]. Vopr Virusol. 1992 Jul-Aug;37(4):178-80. Russian. PMID: 1471338.
Copy Download .nbib Format: NLM
Failure of passively administered anti-Rh to prevent secondary Rh responses.

Vox sanguinis

de Silva M, Contreras M, Mollison PL.
PMID: 2984846
Vox Sang. 1985;48(3):178-80. doi: 10.1111/j.1423-0410.1985.tb00167.x.

Rh-negative women, immunized to Rh by previous pregnancies, with only low concentrations of IgG anti-Rh(D) in their plasma were assigned at random to test and control groups (7 subjects in each group). Both groups were challenged with an intravenous...

Cite
de Silva M, Contreras M, Mollison PL. Failure of passively administered anti-Rh to prevent secondary Rh responses. Vox Sang. 1985;48(3):178-80doi: 10.1111/j.1423-0410.1985.tb00167.x.
de Silva, M., Contreras, M., & Mollison, P. L. (1985). Failure of passively administered anti-Rh to prevent secondary Rh responses. Vox sanguinis, 48(3), 178-80. https://doi.org/10.1111/j.1423-0410.1985.tb00167.x
de Silva, M, et al. "Failure of passively administered anti-Rh to prevent secondary Rh responses." Vox sanguinis vol. 48,3 (1985): 178-80. doi: https://doi.org/10.1111/j.1423-0410.1985.tb00167.x
de Silva M, Contreras M, Mollison PL. Failure of passively administered anti-Rh to prevent secondary Rh responses. Vox Sang. 1985;48(3):178-80. doi: 10.1111/j.1423-0410.1985.tb00167.x. PMID: 2984846.
Copy Download .nbib Format: NLM
[Serological properties of specific immunoglobulin against the Smith strain of Staphylococcus aureus extracted from human sera].

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases

Yoshida K, Ichiman Y, Ohshima Y, Hata H.
PMID: 3932531
Kansenshogaku Zasshi. 1985 May;59(5):433-8. doi: 10.11150/kansenshogakuzasshi1970.59.433.

No abstract available.

Cite
Yoshida K, Ichiman Y, Ohshima Y, et al. [Serological properties of specific immunoglobulin against the Smith strain of Staphylococcus aureus extracted from human sera]. Kansenshogaku Zasshi. 1985;59(5):433-8doi: 10.11150/kansenshogakuzasshi1970.59.433.
Yoshida, K., Ichiman, Y., Ohshima, Y., & Hata, H. (1985). [Serological properties of specific immunoglobulin against the Smith strain of Staphylococcus aureus extracted from human sera]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 59(5), 433-8. https://doi.org/10.11150/kansenshogakuzasshi1970.59.433
Yoshida, K, et al. "[Serological properties of specific immunoglobulin against the Smith strain of Staphylococcus aureus extracted from human sera]." Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases vol. 59,5 (1985): 433-8. doi: https://doi.org/10.11150/kansenshogakuzasshi1970.59.433
Yoshida K, Ichiman Y, Ohshima Y, Hata H. [Serological properties of specific immunoglobulin against the Smith strain of Staphylococcus aureus extracted from human sera]. Kansenshogaku Zasshi. 1985 May;59(5):433-8. doi: 10.11150/kansenshogakuzasshi1970.59.433. Japanese. PMID: 3932531.
Copy Download .nbib Format: NLM
Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis.

Clinical endocrinology

Kraiem Z, Lahat N, Glaser B, Baron E, Sadeh O, Sheinfeld M.
PMID: 2830061
Clin Endocrinol (Oxf). 1987 Oct;27(4):409-21. doi: 10.1111/j.1365-2265.1987.tb01168.x.

The prevalence and characteristics of TSH receptor blocking activity were examined in patients with different thyroid disorders. Studies were also performed on the in-vitro synthesis and immunoregulation of the blocking antibody. Blocking activity was tested by measuring the inhibition...

Cite
Kraiem Z, Lahat N, Glaser B, et al. Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis. Clin Endocrinol (Oxf). 1987;27(4):409-21doi: 10.1111/j.1365-2265.1987.tb01168.x.
Kraiem, Z., Lahat, N., Glaser, B., Baron, E., Sadeh, O., & Sheinfeld, M. (1987). Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis. Clinical endocrinology, 27(4), 409-21. https://doi.org/10.1111/j.1365-2265.1987.tb01168.x
Kraiem, Z, et al. "Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis." Clinical endocrinology vol. 27,4 (1987): 409-21. doi: https://doi.org/10.1111/j.1365-2265.1987.tb01168.x
Kraiem Z, Lahat N, Glaser B, Baron E, Sadeh O, Sheinfeld M. Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis. Clin Endocrinol (Oxf). 1987 Oct;27(4):409-21. doi: 10.1111/j.1365-2265.1987.tb01168.x. PMID: 2830061.
Copy Download .nbib Format: NLM
Phenotypic and functional analysis of B cell lines from patients with multiple myeloma.

Blood

Goldstein M, Hoxie J, Zembryki D, Matthews D, Levinson AI.
PMID: 3893568
Blood. 1985 Aug;66(2):444-6.

We characterized phenotypic and functional properties of B cell lines obtained from patients with multiple myeloma to determine how well they conform to particular stages of B cell differentiation. This information is a prerequisite for using such lines as...

Cite
Goldstein M, Hoxie J, Zembryki D, et al. Phenotypic and functional analysis of B cell lines from patients with multiple myeloma. Blood. 1985;66(2):444-6
Goldstein, M., Hoxie, J., Zembryki, D., Matthews, D., & Levinson, A. I. (1985). Phenotypic and functional analysis of B cell lines from patients with multiple myeloma. Blood, 66(2), 444-6.
Goldstein, M, et al. "Phenotypic and functional analysis of B cell lines from patients with multiple myeloma." Blood vol. 66,2 (1985): 444-6.
Goldstein M, Hoxie J, Zembryki D, Matthews D, Levinson AI. Phenotypic and functional analysis of B cell lines from patients with multiple myeloma. Blood. 1985 Aug;66(2):444-6. PMID: 3893568.
Copy Download .nbib Format: NLM
Antibody-dependent enhancement of human immunodeficiency virus type 1 infection.

Lancet (London, England)

Robinson WE, Montefiori DC, Mitchell WM.
PMID: 2895317
Lancet. 1988 Apr 09;1(8589):790-4. doi: 10.1016/s0140-6736(88)91657-1.

Two components of human serum enhance human immunodeficiency virus type 1 (HIV-1) infection and mask HIV-1 neutralising antibody activity. The first is heat-stable, unique to HIV-1 seropositive sera, and is removed by protein-A chromatography. The second is heat-labile and...

Cite
Robinson WE, Montefiori DC, Mitchell WM. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet. 1988;1(8589):790-4doi: 10.1016/s0140-6736(88)91657-1.
Robinson, W. E., Montefiori, D. C., & Mitchell, W. M. (1988). Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet (London, England), 1(8589), 790-4. https://doi.org/10.1016/s0140-6736(88)91657-1
Robinson, W E, et al. "Antibody-dependent enhancement of human immunodeficiency virus type 1 infection." Lancet (London, England) vol. 1,8589 (1988): 790-4. doi: https://doi.org/10.1016/s0140-6736(88)91657-1
Robinson WE, Montefiori DC, Mitchell WM. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet. 1988 Apr 09;1(8589):790-4. doi: 10.1016/s0140-6736(88)91657-1. PMID: 2895317.
Copy Download .nbib Format: NLM
[Immunoprophylaxis of the vertical transmission of the hepatitis B virus. An urgent need].

Medicina clinica

Genescá J, Esteban R.
PMID: 3959637
Med Clin (Barc). 1986 Jan 18;86(2):63-4.

No abstract available.

Cite
Genescá J, Esteban R. Inmunoprofilaxis de la transmisión vertical del virus de la hepatitis B. Una necesidad urgente. [Immunoprophylaxis of the vertical transmission of the hepatitis B virus. An urgent need]. Med Clin (Barc). 1986;86(2):63-4
Genescá, J., & Esteban, R. (1986). Inmunoprofilaxis de la transmisión vertical del virus de la hepatitis B. Una necesidad urgente. [Immunoprophylaxis of the vertical transmission of the hepatitis B virus. An urgent need]. Medicina clinica, 86(2), 63-4.
Genescá, J, and Esteban, R. "Inmunoprofilaxis de la transmisión vertical del virus de la hepatitis B. Una necesidad urgente." [Immunoprophylaxis of the vertical transmission of the hepatitis B virus. An urgent need]. Medicina clinica vol. 86,2 (1986): 63-4.
Genescá J, Esteban R. Inmunoprofilaxis de la transmisión vertical del virus de la hepatitis B. Una necesidad urgente. [Immunoprophylaxis of the vertical transmission of the hepatitis B virus. An urgent need]. Med Clin (Barc). 1986 Jan 18;86(2):63-4. Spanish. PMID: 3959637.
Copy Download .nbib Format: NLM
Class and subclass anti-pneumococcal antibody responses in splenectomized patients.

Clinical and experimental immunology

Oldfield S, Jenkins S, Yeoman H, Gray D, MacLennan IC.
PMID: 4075589
Clin Exp Immunol. 1985 Sep;61(3):664-73.

Antibody titres against pneumococcal capsular and cell wall antigens and the immune response to polyvalent pneumococcal vaccine were measured in 21 splenectomized patients and 12 healthy controls. Most individuals possessed anti-pneumococcal capsular polysaccharide antibodies of IgG, IgA and IgM...

Cite
Oldfield S, Jenkins S, Yeoman H, et al. Class and subclass anti-pneumococcal antibody responses in splenectomized patients. Clin Exp Immunol. 1985;61(3):664-73
Oldfield, S., Jenkins, S., Yeoman, H., Gray, D., & MacLennan, I. C. (1985). Class and subclass anti-pneumococcal antibody responses in splenectomized patients. Clinical and experimental immunology, 61(3), 664-73.
Oldfield, S, et al. "Class and subclass anti-pneumococcal antibody responses in splenectomized patients." Clinical and experimental immunology vol. 61,3 (1985): 664-73.
Oldfield S, Jenkins S, Yeoman H, Gray D, MacLennan IC. Class and subclass anti-pneumococcal antibody responses in splenectomized patients. Clin Exp Immunol. 1985 Sep;61(3):664-73. PMID: 4075589; PMCID: PMC1577272.
Copy Download .nbib Format: NLM
Immunoregulation: the key to transplantation and autoimmunity.

The Journal of thoracic and cardiovascular surgery

Nossal GJ.
PMID: 3682850
J Thorac Cardiovasc Surg. 1987 Dec;94(6):802-11.

Immune responses depend on a unique set of recognition structures, namely, antibody molecules embedded in the B cell membrane for antibody formation and alpha-beta chain heterodimers of the T cell receptor for cellular immune receptors. These structures are coded...

Cite
Nossal GJ. Immunoregulation: the key to transplantation and autoimmunity. J Thorac Cardiovasc Surg. 1987;94(6):802-11
Nossal, G. J. (1987). Immunoregulation: the key to transplantation and autoimmunity. The Journal of thoracic and cardiovascular surgery, 94(6), 802-11.
Nossal, G J. "Immunoregulation: the key to transplantation and autoimmunity." The Journal of thoracic and cardiovascular surgery vol. 94,6 (1987): 802-11.
Nossal GJ. Immunoregulation: the key to transplantation and autoimmunity. J Thorac Cardiovasc Surg. 1987 Dec;94(6):802-11. PMID: 3682850.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 4233 entries